寒武紀(688256.SH):擬使用不超30億元暫時閒置自有資金購買理財產品
格隆匯12月29日丨寒武紀(688256.SH)公佈,公司於2022年12月29日召開了第二屆董事會第四次會議,審議通過了《關於使用暫時閒置自有資金購買理財產品的議案》,同意公司及控股子公司在不影響日常運營資金週轉需要的前提下,使用額度不超過人民幣30億元(含本數)的暫時閒置自有資金購買安全性高、流動性好的低風險理財產品。在上述額度範圍內,資金可在2023年1月1日至2023年12月31日期間滾動使用,投資的單個理財產品期限不超過12個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.